CHINA SXT PHARMACEUTICALS IN

Q4 2025 13F holders

CUSIP
G2161P157
Type
Equity
Class
SHS NEW JAN 2025
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type